GlassScriptPhysician profile
Stephen H Sherry
NPI 1497856629
$11,329.95
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,916 · 2020: $5,039 · 2023: $360 · 2024: $14.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,304.54 | 2019-2020 | |
| Novo Nordisk INC | $307.62 | 2019-2023 | Rybelsus, Ozempic |
| Amgen INC. | $162.15 | 2019-2023 | Evenity |
| Insulet Corporation | $100.76 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $54.66 | 2019-2024 | Trulance |
| Shire North American Group INC | $53.66 | 2019 | |
| Mannkind Corporation | $43.66 | 2019-2023 | Afrezza |
| Sanofi-Aventis U.S. LLC | $40.80 | 2019 | |
| Lilly USA, LLC | $39.92 | 2019-2023 | Mounjaro |
| Tandem Diabetes Care, INC. | $32.28 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.12 | 2019 | |
| Senseonics, Incorporated | $22.00 | 2019 | |
| Janssen Biotech, INC. | $15.25 | 2023 | Simponi, Simponi Aria, Stelara |
| Ibsa Pharma INC. | $14.50 | 2019 | |
| Abbott Laboratories | $14.49 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $14.22 | 2019 | |
| Merck Sharp & Dohme LLC | $13.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $13.84 | 2019 | |
| Glaxosmithkline, LLC. | $13.71 | 2023 | Trelegy Ellipta |
| Radius Health, INC. | $13.64 | 2019 | |
| Corcept Therapeutics | $13.63 | 2019 | |
| Valeritas, INC. | $12.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Sherry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.